Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REZAFUNGIN vs RIBOFLAVIN 5^-PHOSPHATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REZAFUNGIN vs RIBOFLAVIN 5^-PHOSPHATE: Safety Overview

Metric REZAFUNGIN RIBOFLAVIN 5^-PHOSPHATE
Total FAERS Reports 108 244
Deaths Reported 12 9
Death Rate 11.1% 3.7%
Hospitalizations 20 13
Average Patient Age 53.8 yrs 34.8 yrs
% Female Patients 54.3% 39.6%
FDA Approval Date Mar 22, 2023 N/A
Manufacturer Melinta Therapeutics, LLC N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A